B&G Foods, Inc. (BGS)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Cash & Equivalents	54.08	50.58	41.09	45.44	33.69	52.18
Cash & Short-Term Investments	54.08	50.58	41.09	45.44	33.69	52.18
Cash Growth	34.13%	23.09%	-9.57%	34.88%	-35.44%	361.17%
Accounts Receivable	140.4	172.26	143.02	150.02	145.28	132.94
Other Receivables	1.14	9.07	7.99	8.02	4.28	15.76
Receivables	141.53	181.33	151	158.04	149.57	148.7
Inventory	531.64	511.23	568.98	726.47	609.79	492.8
Prepaid Expenses	35.33	38.3	41.75	37.55	38.15	43.62
Other Current Assets	-	-	-	51.31	3.26	-
Total Current Assets	762.59	781.44	802.82	1,019	834.46	737.3
Property, Plant & Equipment	308.7	334.32	374.17	386.29	406.64	404.07
Goodwill	543.84	548.23	619.4	619.24	644.87	644.75
Other Intangible Assets	1,276	1,286	1,628	1,788	1,927	1,971
Long-Term Deferred Tax Assets	8.93	9.32	15.58	10.02	8.55	4.18
Long-Term Deferred Charges	-	1.4	1.8	2.8	3.7	4.6
Other Long-Term Assets	37.14	33.39	21.68	16.29	3.22	1.35
Total Assets	2,937	2,994	3,463	3,842	3,829	3,768
Accounts Payable	148.69	113.21	123.78	127.81	129.86	126.54
Accrued Expenses	72.42	83.96	83.22	64.14	66.9	77.46
Current Portion of Long-Term Debt	5.63	5.63	22	50	-	-
Current Portion of Leases	16.08	18.69	18.01	15.66	12.42	11.03
Current Income Taxes Payable	1.82	0.34	0.48	0.31	2.56	0.1
Other Current Liabilities	15.2	15.04	14.94	13.62	32.55	30.52
Total Current Liabilities	259.83	236.87	262.42	271.53	244.29	245.65
Long-Term Debt	1,985	2,015	2,023	2,339	2,268	2,334
Long-Term Leases	31.21	37.7	54.45	53.52	55.61	23.96
Long-Term Deferred Tax Liabilities	148.45	168.03	267.05	288.71	310.64	293.12
Other Long-Term Liabilities	11.16	11.83	12.26	12.78	13.64	3.27
Total Liabilities	2,436	2,469	2,628	2,973	2,908	2,936
Common Stock	0.8	0.79	0.79	0.72	0.69	0.64
Additional Paid-In Capital	-	-	46.99	-	3.55	-
Retained Earnings	495.65	528.76	785.09	876.8	934.19	866.83
Comprehensive Income & Other	4.99	-4.74	2.6	-9.35	-18.17	-35.59
Shareholders' Equity	501.43	524.81	835.46	868.17	920.25	831.88
Total Liabilities & Equity	2,937	2,994	3,463	3,842	3,829	3,768
Total Debt	2,038	2,077	2,118	2,458	2,336	2,369
Net Cash (Debt)	-1,984	-2,026	-2,076	-2,413	-2,302	-2,317
Net Cash Per Share	-25.00	-25.64	-27.96	-34.24	-35.01	-35.89
Filing Date Shares Outstanding	80	79.14	78.62	71.67	68.52	64.67
Total Common Shares Outstanding	80.02	79.14	78.62	71.67	68.52	64.25
Working Capital	502.76	544.58	540.41	747.28	590.17	491.65
Book Value Per Share	6.27	6.63	10.63	12.11	13.43	12.95
Tangible Book Value	-1,318	-1,309	-1,412	-1,539	-1,652	-1,784
Tangible Book Value Per Share	-16.47	-16.54	-17.96	-21.48	-24.11	-27.77
Land	-	26.34	26.18	25.51	24.91	25.02
Buildings	-	163.86	163.05	152.34	149.58	159.45
Machinery	-	537.56	525.96	507.41	499.6	478.52
Construction In Progress	-	14.52	13.18	23.15	31.56	23.23

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q